156 related articles for article (PubMed ID: 37890049)
1. A randomized double-blind trial of clonidine and colesevelam for women with fecal incontinence.
Varma R; Feuerhak KJ; Mishra R; Chakraborty S; Oblizajek NR; Bailey KR; Bharucha AE
Neurogastroenterol Motil; 2024 Jan; 36(1):e14697. PubMed ID: 37890049
[TBL] [Abstract][Full Text] [Related]
2. Effects of clonidine in women with fecal incontinence.
Bharucha AE; Fletcher JG; Camilleri M; Edge J; Carlson P; Zinsmeister AR
Clin Gastroenterol Hepatol; 2014 May; 12(5):843-851.e2; quiz e44. PubMed ID: 23891925
[TBL] [Abstract][Full Text] [Related]
3. Effects of Colesevelam on Bowel Symptoms, Biomarkers, and Colonic Mucosal Gene Expression in Patients With Bile Acid Diarrhea in a Randomized Trial.
Vijayvargiya P; Camilleri M; Carlson P; Nair A; Nord SL; Ryks M; Rhoten D; Burton D; Busciglio I; Lueke A; Harmsen WS; Donato LJ
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2962-2970.e6. PubMed ID: 32088296
[TBL] [Abstract][Full Text] [Related]
4. Conservative treatment of severe defecatory urgency and fecal incontinence: minor strategies with major impact.
Ribas Y; Muñoz-Duyos A
Tech Coloproctol; 2018 Sep; 22(9):673-682. PubMed ID: 30251126
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial.
Borup C; Vinter-Jensen L; Jørgensen SPG; Wildt S; Graff J; Gregersen T; Zaremba A; Borup Andersen T; Nøjgaard C; Timm HB; Rainteau D; Hansen SH; Rumessen JJ; Munck LK
Lancet Gastroenterol Hepatol; 2023 Apr; 8(4):321-331. PubMed ID: 36758570
[TBL] [Abstract][Full Text] [Related]
6. Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: a randomized, double-blind, placebo-controlled study.
Beigel F; Teich N; Howaldt S; Lammert F; Maul J; Breiteneicher S; Rust C; Göke B; Brand S; Ochsenkühn T
J Crohns Colitis; 2014 Nov; 8(11):1471-9. PubMed ID: 24953836
[TBL] [Abstract][Full Text] [Related]
7. Obstetric sphincter injury interacts with diarrhea and urgency to increase the risk of fecal incontinence in women with irritable bowel syndrome.
Robinson BL; Matthews CA; Palsson OS; Geller E; Turner M; Parnell B; Crane A; Jannelli M; Wells E; Connolly A; Lin FC; Whitehead WE
Female Pelvic Med Reconstr Surg; 2013; 19(1):40-5. PubMed ID: 23321658
[TBL] [Abstract][Full Text] [Related]
8. Validating endpoints for therapeutic trials in fecal incontinence.
Noelting J; Zinsmeister AR; Bharucha AE
Neurogastroenterol Motil; 2016 Aug; 28(8):1148-56. PubMed ID: 26948292
[TBL] [Abstract][Full Text] [Related]
9. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function.
Odunsi-Shiyanbade ST; Camilleri M; McKinzie S; Burton D; Carlson P; Busciglio IA; Lamsam J; Singh R; Zinsmeister AR
Clin Gastroenterol Hepatol; 2010 Feb; 8(2):159-65. PubMed ID: 19879973
[TBL] [Abstract][Full Text] [Related]
10. The effects of clonidine on symptoms and anorectal sensorimotor function in women with faecal incontinence.
Bharucha AE; Seide BM; Zinsmeister AR
Aliment Pharmacol Ther; 2010 Sep; 32(5):681-8. PubMed ID: 20629973
[TBL] [Abstract][Full Text] [Related]
11. A pharmacological challenge predicts reversible rectal sensorimotor dysfunctions in women with fecal incontinence.
Sharma M; Feuerhak K; Zinsmeister AR; Bharucha AE
Neurogastroenterol Motil; 2018 Oct; 30(10):e13383. PubMed ID: 29856103
[TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome.
Camilleri M; Kim DY; McKinzie S; Kim HJ; Thomforde GM; Burton DD; Low PA; Zinsmeister AR
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):111-21. PubMed ID: 15017503
[TBL] [Abstract][Full Text] [Related]
13. Intrarectal injections of botulinum toxin versus placebo for the treatment of urge faecal incontinence in adults (FI-Toxin): a double-blind, multicentre, randomised, controlled phase 3 study.
Leroi AM; Queralto M; Zerbib F; Siproudhis L; Vitton V; Amarenco G; Etienney I; Mion F; Bridoux V; Philip J; Brochard C; Damon H; Lacroix E; Gillibert A; Gourcerol G
Lancet Gastroenterol Hepatol; 2024 Feb; 9(2):147-158. PubMed ID: 38128556
[TBL] [Abstract][Full Text] [Related]
14. Pelvic floor architectural defects in female patients with urge fecal incontinence versus passive fecal leakage: a dynamic ultrasound study.
Pincus JB; Moss NP; Chang C; Goldberg RP; Rostaminia G
Int Urogynecol J; 2022 Aug; 33(8):2133-2141. PubMed ID: 34292342
[TBL] [Abstract][Full Text] [Related]
15. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.
Huijgen R; Abbink EJ; Bruckert E; Stalenhoef AF; Imholz BP; Durrington PN; Trip MD; Eriksson M; Visseren FL; Schaefer JR; Kastelein JJ;
Clin Ther; 2010 Apr; 32(4):615-25. PubMed ID: 20435231
[TBL] [Abstract][Full Text] [Related]
16. Topical Oxymetazoline for Fecal Incontinence in Patients with Spinal Cord Injury: A Double-Blind Randomized Controlled Crossover Study.
Barak N; Gecse KB; Takács I
Dis Colon Rectum; 2019 Feb; 62(2):234-240. PubMed ID: 30451757
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with biofeedback, loperamide, and stool-bulking agents is effective for the treatment of fecal incontinence in women - a randomized controlled trial.
Sjödahl J; Walter SA; Johansson E; Ingemansson A; Ryn AK; Hallböök O
Scand J Gastroenterol; 2015 Aug; 50(8):965-74. PubMed ID: 25892434
[TBL] [Abstract][Full Text] [Related]
18. Relation of bowel habits to fecal incontinence in women.
Bharucha AE; Seide BM; Zinsmeister AR; Melton LJ
Am J Gastroenterol; 2008 Jun; 103(6):1470-5. PubMed ID: 18510612
[TBL] [Abstract][Full Text] [Related]
19. Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points.
Lacy BE; Chang L; Rao SSC; Heimanson Z; Sayuk GS
Clin Ther; 2023 Mar; 45(3):198-209. PubMed ID: 36922331
[TBL] [Abstract][Full Text] [Related]
20. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
